WALES BREAST CANCER CLINICAL AUDIT (WBCCA) MDT DATA FOR PATIENTS DIAGNOSED in 2009, 2010 and 2011 Singleton Breast Cancer (ABMUHB) MDT.

Slides:



Advertisements
Similar presentations
WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 YSBYTY GWYNEDD (YG) MDT.
Advertisements

Karen Pocock Skin Cancer Clinical Nurse Specialist
West Midlands Cancer Intelligence Unit Extending Quality Assurance to all Breast Cancers: the BCCOM Project UKACR Annual Conference 29 September 2004 Gill.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Professor Arnold Hill Wed 26th October 2011
West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
WALES BREAST CANCER CLINICAL AUDIT (WBCCA) MDT DATA FOR PATIENTS DIAGNOSED in 2009, 2010 and 2011 YSBYTY MAELOR WREXHAM (BCUHB) MDT.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Breast Cancer in Ghana How are we going to ‘beat’ it? Prof J-N Clegg-Lamptey SAMF Launch.
Local Assessment Centres Hayley Heard Head of Programme.
WALES BREAST CANCER CLINICAL AUDIT (WBCCA) MDT DATA FOR PATIENTS DIAGNOSED in 2009, 2010 and 2011 CTUHB (Royal Glamorgan and Price Charles Hospitals) MDT.
Anne Snow, Lead Cancer Nurse Dr Andrew Woolley – Consultant Physician.
Cancer Information Framework Initial feedback on NWCN LUCADA submission 2006 data Wednesday 20 th February, 2008 Linda Roberts, Cancer Information Specialist,
National Oesophago–Gastric Cancer Audit  This slide set is designed to ◦Summarise the main audit findings for presentation at local MDT meetings.
Specialist Breast Units – Does it improve Breast Cancer care? These Power Point presentations are free to download only for academic purposes, with due.
WALES BREAST CANCER CLINICAL AUDIT (WBCCA) MDT DATA FOR PATIENTS DIAGNOSED in 2009, 2010 and 2011 Llandough Hospital (Cardiff and Vale UHB) MDT.
Why did babies die? A review of deaths in Neonatal Units in Wales in 2012 and 2013 Siddhartha Sen Consultant Neonatologist, Royal Gwent Hospital Clinical.
Within the Cancer Program in MUH doing the best research and providing the best care to our patients. This is the best cancer care hospital.cancer care.
Overview: Breast Cancer- Surgical Treatment
Oesophago–Gastric Cancer Audit
Oesophago–Gastric Cancer
All Wales Neonatal Nurse Staffing Audit
APPENDIX 1b: Unscheduled care 2012/13
National Oesophago–Gastric Cancer Audit 2015.
A Model for Breast Services in North Wales
WALES BREAST CANCER CLINICAL AUDIT (WBCCA) MDT DATA FOR PATIENTS DIAGNOSED in 2009, 2010 and 2011 Llandudno General Hospital (BCUHB) MDT.
Outpatient Services.
Role of the Community Specialist Breast Care Nurse
Oesophago–Gastric Cancer
Marcelo Calil Instituto Brasileiro de Controle do Câncer
All Wales Qi Initiative Improving Badgernet Data Quality
Oesophago–Gastric Cancer Audit
WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 PRINCE CHARLES HOSPITAL (PCH) MDT.
WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 YSBYTY GLAN CLWYD (YGC) MDT.
WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 BRONGLAIS HOSPITAL (BRONGLAIS) MDT.
Thanh Nhan Hospital MALE BREAST CANCER: CASE REPORT
Treatment breakdown for prostate cancers
Treatment breakdown for breast cancers
Pathway for patients with suspected Breast Cancer
Antimicrobial use in the 2012 PPS
Treatment breakdown for NSCLC cancers
Update of breast cancer
Treatment breakdown for salivary gland cancers
Treatment breakdown for kidney cancers
Treatment breakdown for liver cancers
Treatment breakdown for larynx cancers
Treatment breakdown for stomach cancers
Treatment breakdown for colon cancers
Treatment breakdown for oropharynx cancers
Treatment breakdown for bladder cancers
Treatment breakdown for pancreatic cancers
Treatment breakdown for oral cavity cancers
Treatment breakdown for uterine cancers
Inquiry into geographical inequalities in breast cancer
Treatment breakdown for rectum cancers
Results from the first National Lung Cancer Organisational Audit.
Treatment breakdown for SCLC cancers
Treatment breakdown for hypopharynx cancers
Treatment breakdown for cervical cancers
Treatment breakdown for ovary cancers
‘Improving Outcomes for people with skin tumours, including Melanoma’
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
A Partnership Approach
Treatment breakdown for other head and neck cancers
Treatment breakdown for vulva cancers
Bliss Baby Charter Audit
Pathway for patients with suspected Breast Cancer
SWAG Network Breast Cancer Site Specific Group
Assessment of Breast and Colorectal Cancer Surgery in Manitoba
Presentation transcript:

WALES BREAST CANCER CLINICAL AUDIT (WBCCA) MDT DATA FOR PATIENTS DIAGNOSED in 2009, 2010 and 2011 Singleton Breast Cancer (ABMUHB) MDT

WBCCA 2009, 2010 AND 2011 – Singleton Hospital Data Completeness See accompanying sheet for key and calculations WBCCA 2009, 2010 AND 2011 – Singleton Hospital

Key Clinical Indicators (KCI) The Cancer National Specialist Advisory Group (NSAG) has established clinical indicators that measure best practice in the management of cancer. These are reviewed annually and those for invasive breast cancer are listed below: KCI1 Pre-operative diagnosis rate (%) in symptomatic breast cancer cases. (minimum: 90%, target 95%) KCI2 % histologically node negative patients having 1-7 nodes removed (minimum: 90%, target 95%) KCI3 % ER positive women who received adjuvant hormonal therapy (minimum: 90%, target 95%) KCI4 % of node positive women (aged <=60 years) who received adjuvant chemotherapy (minimum: 80%, target 90%) KCI5 % of patients who had breast conservation surgery for invasive breast cancer having breast radiotherapy. (minimum: 90%, target 100%) WBCCA 2009, 2010 AND 2011 – Singleton Hospital

WBCCA 2009, 2010 AND 2011 – Singleton Hospital KCI 1 Proportion of invasive symptomatic cases with a pre-operative diagnosis (2011) target minimum WBCCA 2009, 2010 AND 2011 – Singleton Hospital

Primary treatment for invasive cancers (2011)   No. invasive cases Primary surgical treatment Non-surgical treatment Unknown BRONGLAIS GENERAL HOSPITAL 35 27 6 2 GLAN CLWYD CANCER SERVICES 120 105 13 LLANDUDNO GENERAL HOSPITAL 269 242 NEATH PORT TALBOT HOSPITAL 157 145 10 NEVILL HALL HOSPITAL 97 77 20 PRINCE CHARLES HOSPITAL 55 19 1 PRINCE PHILIP HOSPITAL 185 142 36 7 PRINCESS OF WALES HOSPITAL 25 5 ROYAL GLAMORGAN HOSPITAL 215 179 30 ROYAL GWENT HOSPITAL 211 161 47 3 SINGLETON HOSPITAL 240 205 34 LLANDOUGH HOSPITAL 309 264 39 WITHYBUSH GENERAL HOSPITAL 92 69 17 YSBYTY MAELOR WREXHAM 208 166 38 4 ALL WALES 2218 1824 349 45 WBCCA 2009, 2010 AND 2011 – Singleton Hospital

WBCCA 2009, 2010 AND 2011 – Singleton Hospital Variation by hospital in mastectomy rates for all surgically treated invasive breast cancers (2011, all tumour sizes). WBCCA 2009, 2010 AND 2011 – Singleton Hospital

WBCCA 2009, 2010 AND 2011 –Singleton Hospital KCI 2: Variation in the number of nodes removed by hospital from women surgically treated for node negative invasive breast cancers (2011) target minimum WBCCA 2009, 2010 AND 2011 –Singleton Hospital

WBCCA 2009, 2010 AND 2011 – Singleton Hospital Variation in recording of axillary clearance in surgically treated women with histologically node-negative invasive breast cancer (2011) Axillary clearance % Total BRONGLAIS GENERAL HOSPITAL 15 100.0% GLAN CLWYD CANCER SERVICES 9 14.5% 62 LLANDUDNO GENERAL HOSPITAL 17 11.6% 146 NEATH PORT TALBOT HOSPITAL 12.7% 71 NEVILL HALL HOSPITAL 6 12.5% 48 PRINCE CHARLES HOSPITAL 4 22.2% 18 PRINCE PHILIP HOSPITAL 20.7% 87 PRINCESS OF WALES HOSPITAL 0.0% 1 ROYAL GLAMORGAN HOSPITAL 13 10.4% 125 ROYAL GWENT HOSPITAL 7 8.4% 83 SINGLETON HOSPITAL 4.3% 139 LLANDOUGH HOSPITAL 3.7% 161 WITHYBUSH GENERAL HOSPITAL 3.0% 33 YSBYTY MAELOR WREXHAM 11 10.6% 104 ALL WALES 122 11.2% 1093 WBCCA 2009, 2010 AND 2011 – Singleton Hospital

WBCCA 2009, 2010 AND 2011 – Singleton Hospital Variation in clearance of margins by hospital for invasive breast cancers following final surgery by breast conservation (2009-2011) WBCCA 2009, 2010 AND 2011 – Singleton Hospital

WBCCA 2009, 2010 AND 2011 – Singleton Hospital KCI 5: Variation in radiotherapy given after conservative surgery for invasive breast cancers (2009-2011) target minimum WBCCA 2009, 2010 AND 2011 – Singleton Hospital

WBCCA 2009, 2010 AND 2011 – Singleton Hospital Variation by hospital in age of invasive breast cancers receiving no radiotherapy after conservative surgery (2009-2011) 2009-2011 DATA <65 % 65+ BRONGLAIS GENERAL HOSPITAL 0.0% 4 50.0% GLAN CLWYD CANCER SERVICES 16 16.7% 11 13.8% LLANDUDNO GENERAL HOSPITAL 39 14.5% 18 10.2% NEATH PORT TALBOT HOSPITAL 14 8.1% 7 7.1% NEVILL HALL HOSPITAL 5 4.5% 7.3% PRINCE CHARLES HOSPITAL 3 12.5% PRINCE PHILIP HOSPITAL 10.7% 10 10.4% PRINCESS OF WALES HOSPITAL ROYAL GLAMORGAN HOSPITAL 5.9% 6.5% ROYAL GWENT HOSPITAL 17 10.6% SINGLETON HOSPITAL 19 7.2% 8 6.8% LLANDOUGH HOSPITAL 12 4.0% 4.8% WITHYBUSH GENERAL HOSPITAL 3.6% 19.0% YSBYTY MAELOR WREXHAM 24 ALL WALES 186 8.6% 121 9.9% WBCCA 2009, 2010 AND 2011 – Singleton Hospital

WBCCA 2009, 2010 AND 2011 – Singleton Hospital KCI 3: patients with invasive ER positive breast cancer receiving adjuvant hormone therapy (2011) target minimum WBCCA 2009, 2010 AND 2011 – Singleton Hospital

WBCCA 2009, 2010 AND 2011 – Singleton Hospital KCI 4: Variation by hospital of node positive invasive cases, under 61 years of age, receiving chemotherapy following surgery (2009-2011) target minimum WBCCA 2009, 2010 AND 2011 – Singleton Hospital

WBCCA 2009, 2010 AND 2011 – Singleton Hospital Variation in ER and HER-2 negative breast cancers receiving chemotherapy (2011) WBCCA 2009, 2010 AND 2011 – Singleton Hospital

Further information and feedback Full report on Cancer NSAG website DN: add link For audit queries and feedback contact clinical leads, information leads, analysts or cancer NSAG colorectal group representatives via Louise.Carrington@wales.nhs.uk For Network resources to help improve outcomes contact: SOUTH WALES CANCER NETWORK (SWCN) Hywel.Morgan2@wales.nhs.uk. Tom.Crosby@Wales.NHS.UK NORTH WALES CANCER NETWORK (NWCN) Damian.Heron@Wales.NHS.UK Caroline.Williams@Wales.NHS.UK Cancer NSAG Breast group Dr Kate Gower Thomas (Chair) Radiologist Dr Peter Barrett-Lee (Deputy Chair) Clinical Oncologist Prof Robert Mansel Surgeon Mr Ian Monypenny Mr Rhodri Williams Dr Andy Gash Radiologist Dr Nick Dallimore Histopathologist Rosemary Fox Deputy Director of Screening Dr Gianfilippo Bertelli Medical Oncologist Sue Brady Nurse Mr Walid Samra NWCN Tumour Site Lead Mr Simon Holt SWCN Tumour Site Lead Dr Jacinta Abraham SWCN Tumour Site Deputy WBCCA 2009, 2010 AND 2011 – Singleton Hospital